Skip to content

blood concentrates will be used for the growth of gums in this clinical trial

Effect of injectable PRF (i-PRF) as a minimally invasive approach for reconstruction of interdental papilla: A clinical study

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/08/020668
Enrollment
10
Registered
2019-08-09
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 8- Other Procedures

Interventions

Intervention1: using blood concentrate for growth of gums: we will inject the blood concentrate ie injectable platelet rich fibrin directly into the middle of the papilla, 3-4 mm apical to the tip of

Sponsors

ABHINAV GARG
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Systemically healthy adults >=18 years old. 2. Full mouth gingival index (Loe & Silness, 1963) score 3. Full mouth plaque index (Silness & Loe, 1964) score 4. Atleast one maxillary or mandibular interdental space exhibiting class I or II or III interdental papilla using Nordland & Tarnow classification system, 1998

Exclusion criteria

Exclusion criteria: 1.Smokers and tobacco in any form. 2.Pregnancy & Lactation. 3.Medications known to increase gingival hyperplasia. 4.Periodontal surgery in the last 12 months on study teeth. 5.Carious lesions or fixed restorations on study teeth. 6.Inadequate Platelet count 7.Patient not willing to give written informed consent form.

Design outcomes

Primary

MeasureTime frame
Total number of 10 sample size with atleast one maxillary or mandibular anterior interdental papilla loss will be includedTimepoint: Total number of 10 sample size with atleast one maxillary or mandibular anterior interdental papilla loss will be included

Secondary

MeasureTime frame
1.To assess the Patient Related Outcome using Questionnaire and Visual Analogue Scale (VAS), pre and post treatment.Timepoint: 1.To assess the Patient Related Outcome using Questionnaire and Visual Analogue Scale (VAS), pre and post treatment.

Countries

India

Contacts

Public ContactABHINAV GARG

SCHOOL OF DENTAL SCIENCES SHARDA UNIVERSITY

sidami22@yahoo.co.in9810256106

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026